Related Experiment Video
Updated: Apr 27, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
13.7K
C-Met expression pattern in uterine leiomyoma
Clinical and Experimental Obstetrics & Gynecology
|July 5, 2014
Summary
Hepatocyte growth factor (HGF) and its receptor c-Met are implicated in uterine leiomyoma (LM) development. Overexpression of c-Met was observed in all LM tissues but not in normal myometrium, suggesting a role for this pathway.
Area of Science:
- Reproductive biology
- Cell signaling
- Oncology
Background:
- Growth factors are crucial in uterine leiomyoma (LM) pathogenesis.
- Known factors include TGF-β, EGF, PDGF, VEGF, FGF-2, and IGF.
- The role of hepatocyte growth factor (HGF) and its receptor c-Met in LMs is largely unexplored.
Purpose of the Study:
- To investigate the expression of the c-Met receptor in human myometrium and uterine leiomyomas.
- To determine the potential involvement of the HGF/c-Met pathway in LM development.
Main Methods:
- Immunohistochemical analysis was used to evaluate c-Met receptor expression.
- The study included samples of human myometrium and uterine leiomyomas.
Main Results:
- Overexpression of c-Met was detected in all examined uterine leiomyoma samples.
- No overexpression of c-Met was observed in normal myometrium tissues.
Conclusions:
- The HGF/c-Met receptor complex appears to play a significant role in the development of uterine leiomyomas.
- Further research into the HGF/c-Met pathway could reveal novel therapeutic targets for LMs.
